| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) | 
|---|
| 08/31/2005 | EP1567494A1 Methods for preparing phenylalkyne derivatives  | 
| 08/31/2005 | EP1567477A1 Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors  | 
| 08/31/2005 | EP1567010A1 Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides  | 
| 08/31/2005 | EP1011676B1 Quinoline-urea derivatives for the treatment of withdrawal syndrome and withdrawal-induced brain damage  | 
| 08/31/2005 | CN1662540A 2-(quinolonyl)-fused heterocycles as androgen receptor modulators  | 
| 08/31/2005 | CN1662521A Compounds useful for the treatment of obesity, type ii diabetes and cns disorders  | 
| 08/31/2005 | CN1662505A Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same  | 
| 08/31/2005 | CN1660818A Process for the manufacture of organic compounds  | 
| 08/31/2005 | CN1660812A New medical salt and preparation in group of carbostyril mandelate and preparing method  | 
| 08/31/2005 | CN1660811A Compound of 1, 4-substituted benzenes and preparing method and application  | 
| 08/30/2005 | US6936615 Heteroaryl derivatives and their use as medicaments  | 
| 08/30/2005 | CA2336968C Quinoline derivatives  | 
| 08/25/2005 | WO2005077947A1 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders  | 
| 08/25/2005 | WO2005077904A1 Process for preparing aripiprazole  | 
| 08/25/2005 | WO2005077903A2 Melanin concentrating hormone receptor ligands: substituted tetrahydroisoquinoline analogues  | 
| 08/25/2005 | WO2005077898A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics  | 
| 08/25/2005 | WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both  | 
| 08/25/2005 | WO2005077884A2 Hydroaminomethylation of olefins  | 
| 08/25/2005 | WO2005076861A2 Compounds that inhibit hiv particle formation  | 
| 08/25/2005 | WO2005011601A3 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders  | 
| 08/25/2005 | US20050187375 Polymers and oligomers, their synthesis, and electronic devices incorporating same  | 
| 08/25/2005 | US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction  | 
| 08/25/2005 | US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine  | 
| 08/25/2005 | US20050187251 Substituted N-heterocycle derivatives and methods of their use  | 
| 08/25/2005 | US20050187245 Stable amorphous forms of montelukast sodium  | 
| 08/25/2005 | US20050187244 Montelukast sodium polymorphs  | 
| 08/25/2005 | US20050187243 Montelukast free acid polymorphs  | 
| 08/25/2005 | US20050187230 Compounds and compositions as protein kinase inhibitors  | 
| 08/25/2005 | CA2556084A1 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders  | 
| 08/25/2005 | CA2555289A1 Process for preparing aripiprazole  | 
| 08/25/2005 | CA2555132A1 Compounds that inhibit hiv particle formation  | 
| 08/25/2005 | CA2552565A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics  | 
| 08/24/2005 | EP1566379A1 QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME  | 
| 08/24/2005 | EP1565472A2 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure  | 
| 08/24/2005 | EP1565443A2 Acetyl 2-hydroxy-1,3 diaminoalkanes  | 
| 08/24/2005 | EP1565428A1 Substituted ureas and carbamates  | 
| 08/24/2005 | EP1565185A2 Neuroprotective iron chelators and pharmaceutical compositions comprising them  | 
| 08/24/2005 | EP1334085B1 Sulfamides as gamma-secretase inhibitors  | 
| 08/24/2005 | EP1299349B1 Compounds to treat alzheimer's disease  | 
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists  | 
| 08/24/2005 | CN1659156A Novel guanidinobenzamides  | 
| 08/24/2005 | CN1659146A Process for the manufacture of quinoline derivatives  | 
| 08/24/2005 | CN1659145A 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases  | 
| 08/24/2005 | CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors  | 
| 08/24/2005 | CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity  | 
| 08/24/2005 | CN1658877A Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom  | 
| 08/24/2005 | CN1658724A Luminescent element material and luminescent element comprising the same  | 
| 08/23/2005 | US6933388 Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolones  | 
| 08/18/2005 | WO2005075430A1 Process for preparing purified ciprofloxacin  | 
| 08/18/2005 | WO2005075429A1 Novel quinoline-carbaxamides as jack3 kinase modulators  | 
| 08/18/2005 | WO2005075428A1 Quinoline derivatives for use as mycobacterial inhibitors  | 
| 08/18/2005 | WO2005075427A2 Montelukast sodium polymorphs  | 
| 08/18/2005 | WO2005074935A1 Montelukast free acid polymorphs  | 
| 08/18/2005 | WO2005074919A1 Diurea derivatives  | 
| 08/18/2005 | WO2005074893A1 Stable amorphous forms of montelukast sodium  | 
| 08/18/2005 | WO2004026837A3 Histamine h3 receptor antagonists, preparaton and therapeutic uses  | 
| 08/18/2005 | US20050182259 Subjecting a substituted quinoline-3-carboxamide compound to Hofmann degradation to obtain amine derivative, forming diazonium salt by reacting amine derivative with borontrifluoride-ethyl ether complex, heating to form 3-fluoroquinolines; intermediate for forming antibacterial compound  | 
| 08/18/2005 | US20050182253 N,N,N',N'-tetrakis(2-quinolylmethyl)ethylenediamine; reacting with Zinc ions; inhibition of photoinduced electron transfer (PET)  | 
| 08/18/2005 | US20050182093 Novel compounds  | 
| 08/18/2005 | US20050182087 antidiabetic agents; type 2 diabetes; e.g. 1-Ethyl-6-(1-ethynylcyclohexylamino)-7-methyl-4-oxo-1,4-dihydro-(1,8)naphthyridine-3-carboxylate  | 
| 08/18/2005 | US20050182085 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments  | 
| 08/18/2005 | US20050182068 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues  | 
| 08/18/2005 | US20050182054 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases  | 
| 08/18/2005 | US20050182050 Therapeutic heterocyclic compounds  | 
| 08/18/2005 | US20050182047 Treatment of demyelinating disorders  | 
| 08/18/2005 | CA2554927A1 Stable amorphous forms of montelukast sodium  | 
| 08/18/2005 | CA2554789A1 Montelukast sodium polymorphs  | 
| 08/18/2005 | CA2554572A1 Montelukast free acid polymorphs  | 
| 08/18/2005 | CA2551566A1 Diurea derivatives  | 
| 08/17/2005 | EP1564210A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors  | 
| 08/17/2005 | EP1563852A1 Compounds which can be used to diagnose and monitor diseases associated with the formation of amyloid protein fibrils  | 
| 08/17/2005 | EP1562924A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders  | 
| 08/17/2005 | EP1562923A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders  | 
| 08/17/2005 | EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication  | 
| 08/17/2005 | EP1499594B1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles  | 
| 08/17/2005 | EP1280757B1 New gamma selective retinoids  | 
| 08/17/2005 | EP1196397B1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases  | 
| 08/17/2005 | EP1099694B1 Process for the preparation of quinoline derivative and intermediate therefor  | 
| 08/17/2005 | EP0894085B1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors  | 
| 08/17/2005 | CN1656075A Quinoline derivatives and their use as 5-HT6 ligands  | 
| 08/17/2005 | CN1656072A Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors  | 
| 08/17/2005 | CN1215055C Arylsulfonamido-substituted hydroxamic acid derivatives  | 
| 08/17/2005 | CN1215054C Microbicidal N-sulfonylglycin alkynyloxyphenemethyl amide derivatives  | 
| 08/16/2005 | US6930185 Anorectic agents; obesity; such as 4'-chloro-N-(6-((N,N-dimethylamino)methyl)-2-naphthyl)(1,1'-biphenyl)-4 -carbox-amide  | 
| 08/16/2005 | US6930113 For therapy and prophylaxis of sexual dysfunctios; hypertension, pulmonary hypertension, congestive heart failure, renal failure, myocardial infraction, stable, unstable and variant (Prinzmetal) angina, atherosclerosis  | 
| 08/16/2005 | US6930104 beta -amyloid precursor protein secretory stimulators; treating neurodegenerative disorders; n-carbamoyl- quinoxaline or quinoline derivatives  | 
| 08/16/2005 | US6929870 Hydrocarbon compounds, materials for organic electroluminescent elements and organic electroluminescent elements  | 
| 08/11/2005 | WO2005073230A1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments  | 
| 08/11/2005 | WO2005073229A1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments  | 
| 08/11/2005 | WO2005073216A2 Hcv ns-3 serine protease inhibitors  | 
| 08/11/2005 | WO2005073195A2 Hcv ns-3 serine protease inhibitors  | 
| 08/11/2005 | WO2005073194A2 Solid forms of montelukast acid  | 
| 08/11/2005 | WO2005073165A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide  | 
| 08/11/2005 | WO2005058835A3 Methods of preparing aripiprazole crystalline forms  | 
| 08/11/2005 | WO2005053663A3 Norepinephrine reuptake inhibitors useful for treatment of cognitive failure  | 
| 08/11/2005 | WO2005051302A3 Bicyclic inhibitors of mek and methods of use thereof  | 
| 08/11/2005 | WO2005034856A3 Targeted drug-formaldehyde conjugates and methods of making and using the same  | 
| 08/11/2005 | WO2005023188A3 Compounds and methods  | 
| 08/11/2005 | WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression  | 
| 08/11/2005 | WO2004110983A8 New benzamides as pparϒ modulators  |